Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-27

Clinical Trial Update: Platelet Rich Plasma in Treatment of Melasma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining Platelet Rich Plasma for treating Melasma, with current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Assiut University | Conditions: Melasma, Platelet Rich Plasma | Phase 3 | Status: UNKNOWN